Moberg Pharma AB (OSTO:MOB) FCF Yield % : -20.68 (As of May. 28, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Moberg Pharma AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Moberg Pharma AB's Trailing 12-Month Free Cash Flow is kr-138.26 Mil, and Market Cap is kr668.28 Mil. Therefore, Moberg Pharma AB's FCF Yield % for today is -20.68%.

The historical rank and industry rank for Moberg Pharma AB's FCF Yield % or its related term are showing as below:

OSTO:MOB' s FCF Yield % Range Over the Past 10 Years
Min: -445.39 Med: -36.66 Max: 14.82
Current: -20.68

During the past 13 years, the highest FCF Yield % of Moberg Pharma AB was 14.82%. The lowest was -445.39%. And the median was -36.66%.

OSTO:MOB's FCF Yield % is ranked worse than
83.36% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.335 vs OSTO:MOB: -20.68

Moberg Pharma AB's FCF Margin % for the quarter that ended in Mar. 2024 was -2,635.61%.

Moberg Pharma AB FCF Yield % Historical Data

The historical data trend for Moberg Pharma AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB FCF Yield % Chart

Moberg Pharma AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-1.28

-42.17

-19.70

-37.25

-37.02

Moberg Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-60.02	-141.67	-102.42	-38.18	-13.68

Competitive Comparison of Moberg Pharma AB's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moberg Pharma AB's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's FCF Yield % falls into.

Moberg Pharma AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Moberg Pharma AB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-157.321	/	425.0148
	=	-37.02%

Moberg Pharma AB's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-21.612	*	4	/	631.9299
	=	-13.68%

Moberg Pharma AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Moberg Pharma AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Moberg Pharma AB (OSTO:MOB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OSTO:MOB) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

MB8:Germany

Address

Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51

Website

https://www.mobergpharma.se

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.